Meeting
2024 ASCO Quality Care Symposium
A prospective, longitudinal study of health-related quality of life and contributing factors and its impact on medication adherence to oral anticancer agents in real-world patients with leukemia.
Authors
Benyam Muluneh
Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC
Benyam Muluneh , Emily Ong , Abigail Danos , Daniel R Richardson , Ashley Leak Bryant , Jennifer Elston Lafata
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care
Sub Track
Symptom Prevention, Assessment, and Management
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 270)
DOI
10.1200/OP.2024.20.10_suppl.270
Abstract #
270
Poster Bd #
E15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Comparison of next-generation sequencing and flow cytometry in detecting minimal residual disease in adult acute lymphoid leukemia: Evaluating clinical outcomes in a single-center study.
First Author: Vinay Nittur
Poster
2020 ASCO Virtual Scientific Program
Evaluation of CD22 modulation as a mechanism of resistance to inotuzumab ozogamicin (InO): Results from central CD22 testing on the Children’s Oncology Group (COG) phase II trial of INO in children and young adults with CD22+ B-acute lymphoblastic leukemia (B-ALL).
First Author: Nirali N. Shah
Poster
2019 ASCO Annual Meeting
Allogeneic stem cell transplantation (AlloSCT) for patients (pts) with acute leukemia following venetoclax-based therapy.
First Author: Akash Mukherjee
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells.
First Author: Kristen Fousek